CN103772440A - 一种锝-99m标记的高级脂肪酸衍生物 - Google Patents
一种锝-99m标记的高级脂肪酸衍生物 Download PDFInfo
- Publication number
- CN103772440A CN103772440A CN201410010571.3A CN201410010571A CN103772440A CN 103772440 A CN103772440 A CN 103772440A CN 201410010571 A CN201410010571 A CN 201410010571A CN 103772440 A CN103772440 A CN 103772440A
- Authority
- CN
- China
- Prior art keywords
- fatty acid
- compound
- technetium
- higher fatty
- acid derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000014113 dietary fatty acids Nutrition 0.000 title claims abstract description 43
- 229930195729 fatty acid Natural products 0.000 title claims abstract description 43
- 239000000194 fatty acid Substances 0.000 title claims abstract description 43
- 150000004665 fatty acids Chemical class 0.000 title claims abstract description 41
- GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 title claims abstract description 35
- 229940056501 technetium 99m Drugs 0.000 title claims abstract description 35
- 230000002107 myocardial effect Effects 0.000 abstract description 16
- 210000004165 myocardium Anatomy 0.000 abstract description 15
- 239000003814 drug Substances 0.000 abstract description 11
- 230000014759 maintenance of location Effects 0.000 abstract description 7
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 abstract description 5
- 230000004129 fatty acid metabolism Effects 0.000 abstract description 3
- 150000002632 lipids Chemical class 0.000 abstract description 3
- 238000002474 experimental method Methods 0.000 abstract description 2
- -1 fatty acid compounds Chemical class 0.000 abstract description 2
- 150000004668 long chain fatty acids Chemical class 0.000 abstract 3
- 230000002035 prolonged effect Effects 0.000 abstract 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 description 58
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
- 238000003756 stirring Methods 0.000 description 36
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 33
- 239000000243 solution Substances 0.000 description 28
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 230000004060 metabolic process Effects 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 238000002156 mixing Methods 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 0 CCC(C)CC(C)(CC)C(C(*)CC1*C1)C(CC)C1*CCCC1 Chemical compound CCC(C)CC(C)(CC)C(C(*)CC1*C1)C(CC)C1*CCCC1 0.000 description 10
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 description 10
- 238000000605 extraction Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 241000700159 Rattus Species 0.000 description 8
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical group CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 230000002503 metabolic effect Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 238000004821 distillation Methods 0.000 description 5
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- 239000002207 metabolite Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- YCBILDINMXDZBY-UHFFFAOYSA-N C(CC)(=O)Cl.S1C=CC=C1 Chemical compound C(CC)(=O)Cl.S1C=CC=C1 YCBILDINMXDZBY-UHFFFAOYSA-N 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- 229910052794 bromium Inorganic materials 0.000 description 4
- TVIDDXQYHWJXFK-UHFFFAOYSA-N dodecanedioic acid Chemical compound OC(=O)CCCCCCCCCCC(O)=O TVIDDXQYHWJXFK-UHFFFAOYSA-N 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 238000013399 early diagnosis Methods 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 238000003818 flash chromatography Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000012217 radiopharmaceutical Substances 0.000 description 3
- 229940121896 radiopharmaceutical Drugs 0.000 description 3
- 230000002799 radiopharmaceutical effect Effects 0.000 description 3
- 229910052713 technetium Inorganic materials 0.000 description 3
- GKLVYJBZJHMRIY-UHFFFAOYSA-N technetium atom Chemical compound [Tc] GKLVYJBZJHMRIY-UHFFFAOYSA-N 0.000 description 3
- WHLUQAYNVOGZST-UHFFFAOYSA-N tifenamil Chemical group C=1C=CC=CC=1C(C(=O)SCCN(CC)CC)C1=CC=CC=C1 WHLUQAYNVOGZST-UHFFFAOYSA-N 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- ICMAFTSLXCXHRK-UHFFFAOYSA-N Ethyl pentanoate Chemical compound CCCCC(=O)OCC ICMAFTSLXCXHRK-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000020057 cognac Nutrition 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940017219 methyl propionate Drugs 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- ZJTIWHPJLWKXCT-UHFFFAOYSA-N propanoic acid;thiophene Chemical compound CCC(O)=O.C=1C=CSC=1 ZJTIWHPJLWKXCT-UHFFFAOYSA-N 0.000 description 2
- 239000000941 radioactive substance Substances 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 229910052702 rhenium Inorganic materials 0.000 description 2
- WUAPFZMCVAUBPE-UHFFFAOYSA-N rhenium atom Chemical compound [Re] WUAPFZMCVAUBPE-UHFFFAOYSA-N 0.000 description 2
- 238000002603 single-photon emission computed tomography Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 229930192474 thiophene Natural products 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- FCSKOFQQCWLGMV-UHFFFAOYSA-N 5-{5-[2-chloro-4-(4,5-dihydro-1,3-oxazol-2-yl)phenoxy]pentyl}-3-methylisoxazole Chemical compound O1N=C(C)C=C1CCCCCOC1=CC=C(C=2OCCN=2)C=C1Cl FCSKOFQQCWLGMV-UHFFFAOYSA-N 0.000 description 1
- QKACYQWDJUWOFA-VZLNHYCJSA-N CCC1[C@]2(C)N[C@@H]12 Chemical compound CCC1[C@]2(C)N[C@@H]12 QKACYQWDJUWOFA-VZLNHYCJSA-N 0.000 description 1
- DGWZGZSZVXVVPK-UHFFFAOYSA-N CCc1ccc(C=O)[nH]1 Chemical compound CCc1ccc(C=O)[nH]1 DGWZGZSZVXVVPK-UHFFFAOYSA-N 0.000 description 1
- IHJRUDDZMSYFHW-XLLULAGJSA-N C[C@@H]1[O]=C(C)C1(C)CC(C)(C)c1ccc[s]1 Chemical compound C[C@@H]1[O]=C(C)C1(C)CC(C)(C)c1ccc[s]1 IHJRUDDZMSYFHW-XLLULAGJSA-N 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 229910006124 SOCl2 Inorganic materials 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 238000001948 isotopic labelling Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000020925 non fasting Nutrition 0.000 description 1
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 230000004783 oxidative metabolism Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000003496 technetium compounds Chemical class 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- QMQNSXDOUHTBBP-UHFFFAOYSA-N thiophen-2-ylmethyl propanoate Chemical compound CCC(=O)OCC1=CC=CS1 QMQNSXDOUHTBBP-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (9)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410010571.3A CN103772440B (zh) | 2014-01-10 | 2014-01-10 | 一种锝‑99m标记的高级脂肪酸衍生物 |
PCT/CN2015/000087 WO2015103946A1 (zh) | 2014-01-10 | 2015-02-09 | 一种锝-99m标记的高级脂肪酸衍生物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410010571.3A CN103772440B (zh) | 2014-01-10 | 2014-01-10 | 一种锝‑99m标记的高级脂肪酸衍生物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103772440A true CN103772440A (zh) | 2014-05-07 |
CN103772440B CN103772440B (zh) | 2017-02-15 |
Family
ID=50565254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410010571.3A Expired - Fee Related CN103772440B (zh) | 2014-01-10 | 2014-01-10 | 一种锝‑99m标记的高级脂肪酸衍生物 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN103772440B (zh) |
WO (1) | WO2015103946A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107674098A (zh) * | 2017-06-26 | 2018-02-09 | 方纬 | 一类含芳基硼酸的99mTc配合物及其药盒配方和应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102311459A (zh) * | 2011-06-03 | 2012-01-11 | 北京师范大学 | 新型锝-99m标记的高级脂肪酸衍生物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06501450A (ja) * | 1990-06-01 | 1994-02-17 | インスティトゥート フュア ディアグノスティックフォルシュング ゲゼルシャフト ミット ベシュレンクテル ハフツング アン デア フライエン ウニヴェルジテート ベルリン | シクロペンタジエニルカルボニル―99mTc錯体、その製造法および診断学への該化合物の使用 |
US5700446A (en) * | 1996-06-13 | 1997-12-23 | Neuro Imaging Technologies, Llc | Synthesis of ferrocenyl phenyltropane analogs and their radio-transformation to technetium neuroprobes for mapping monoamine reuptake sites |
-
2014
- 2014-01-10 CN CN201410010571.3A patent/CN103772440B/zh not_active Expired - Fee Related
-
2015
- 2015-02-09 WO PCT/CN2015/000087 patent/WO2015103946A1/zh active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102311459A (zh) * | 2011-06-03 | 2012-01-11 | 北京师范大学 | 新型锝-99m标记的高级脂肪酸衍生物 |
Non-Patent Citations (1)
Title |
---|
HUAHUI ZENG ET AL.: "Synthesis and biological evaluation of fatty acids conjugates bearing cyclopentadienyl-donors incorporated [99mTc/Re(CO)3]+ for myocardical imaging", 《EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107674098A (zh) * | 2017-06-26 | 2018-02-09 | 方纬 | 一类含芳基硼酸的99mTc配合物及其药盒配方和应用 |
CN107674098B (zh) * | 2017-06-26 | 2021-12-07 | 中国医学科学院阜外医院 | 一类含芳基硼酸的99mTc配合物及其药盒配方和应用 |
Also Published As
Publication number | Publication date |
---|---|
WO2015103946A1 (zh) | 2015-07-16 |
CN103772440B (zh) | 2017-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101555232B (zh) | 氟-18标记哒嗪酮类化合物及制备方法和应用 | |
CN103113354B (zh) | 一种含peg化苄基三唑基的哒嗪酮类化合物及其制备方法和应用 | |
US11628228B2 (en) | 99mTc-labeled isonitrile-containing glucose derivative and preparation method and use thereof | |
CN111138504B (zh) | 一种99mTc-CNPEDG配合物及其制备方法和应用 | |
CN102336741A (zh) | 氟-18标记的心肌灌注显像剂及其制备方法和应用 | |
WO2022077923A1 (zh) | 一种含苯环的葡萄糖衍生物及其应用 | |
CN110183493B (zh) | 一种99m锝标记配合物及其在诊断非小细胞肺癌中的应用 | |
CN102421454A (zh) | 用于显像脂肪酸代谢和存储的pet放射性示踪剂 | |
Choi et al. | Synthesis and evaluation of an 125I-labeled azide prosthetic group for efficient and bioorthogonal radiolabeling of cyclooctyne-group containing molecules using copper-free click reaction | |
AlJammaz et al. | Novel synthesis and initial preclinical evaluation of 18F-[FDG] labeled rhodamine: a potential PET myocardial perfusion imaging agent | |
CN103772440A (zh) | 一种锝-99m标记的高级脂肪酸衍生物 | |
CN102311459B (zh) | 新型锝-99m标记的高级脂肪酸衍生物 | |
CN102898470B (zh) | 一类新型有机膦化合物及其制备方法和应用 | |
CN103497217A (zh) | 与Aβ斑块具有高亲和力的2-芳基苯并噻唑类化合物、其制备方法及应用 | |
CN102146098B (zh) | 一种99mTc标记D-葡萄糖配合物的制备方法及应用 | |
CN101475595B (zh) | 99TcmN核标记硝基咪唑类黄原酸盐配合物及制备方法和应用 | |
WO2023001004A1 (zh) | 一种甘露糖衍生物及其应用 | |
CN114031652A (zh) | 一种含环己烷的葡萄糖衍生物及其应用 | |
CN107674098B (zh) | 一类含芳基硼酸的99mTc配合物及其药盒配方和应用 | |
CN108191603B (zh) | 一种3-18f-氟代乳酸类似物及其制备方法与应用 | |
CN102827208B (zh) | 99mTcO核标记蛋氨酸氨荒酸盐配合物的制备方法和应用 | |
CN105198930B (zh) | 双吡啶类三羰基锝-99m标记的长链脂肪酸衍生物及其应用 | |
CN105524113B (zh) | 99mTcN核标记含三唑环的葡萄糖氨荒酸盐配合物及制备方法和应用 | |
CN101768079A (zh) | 化合物及药用用途 | |
CN101851313B (zh) | 锝-99m标记的聚N-乙烯基苄基-D-乳糖酰胺配合物及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Huabei Inventor after: Liu Jianping Inventor after: Li Xiang Inventor after: Xue Qianqian Inventor after: Xue Tian Inventor before: Zhang Huabei Inventor before: Xue Tian Inventor before: Li Xiang |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHANG HUABEI XUE TIAN LI XIANG TO: ZHANG HUABEI LIU JIANPING LI XIANG XUE QIANQIAN XUE TIAN |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170215 Termination date: 20180110 |